Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Human | 9 | 2023 | 4417 | 0.940 |
Why?
|
| Gene Amplification | 3 | 2021 | 1085 | 0.720 |
Why?
|
| Chromosome Breakage | 2 | 2020 | 159 | 0.650 |
Why?
|
| Haplotypes | 3 | 2023 | 2764 | 0.640 |
Why?
|
| Mutagenesis | 4 | 2020 | 1234 | 0.610 |
Why?
|
| Sequence Analysis, DNA | 6 | 2023 | 4713 | 0.600 |
Why?
|
| Micronuclei, Chromosome-Defective | 2 | 2015 | 38 | 0.530 |
Why?
|
| Oncogenes | 1 | 2021 | 1220 | 0.520 |
Why?
|
| Single-Cell Analysis | 7 | 2020 | 2380 | 0.500 |
Why?
|
| Gene Rearrangement | 4 | 2018 | 1122 | 0.450 |
Why?
|
| Statistics as Topic | 2 | 2021 | 2362 | 0.430 |
Why?
|
| Chromosomes | 3 | 2023 | 575 | 0.420 |
Why?
|
| DNA Damage | 3 | 2020 | 2442 | 0.350 |
Why?
|
| DNA Copy Number Variations | 4 | 2016 | 2013 | 0.340 |
Why?
|
| Genomic Instability | 3 | 2021 | 704 | 0.320 |
Why?
|
| DNA | 1 | 2022 | 7233 | 0.320 |
Why?
|
| Membrane Fluidity | 1 | 2008 | 68 | 0.310 |
Why?
|
| Genomics | 4 | 2018 | 5794 | 0.300 |
Why?
|
| Genome | 1 | 2016 | 1739 | 0.300 |
Why?
|
| Neoplasms | 6 | 2022 | 22072 | 0.290 |
Why?
|
| Focal Adhesions | 1 | 2008 | 114 | 0.290 |
Why?
|
| Gene Dosage | 4 | 2021 | 1218 | 0.290 |
Why?
|
| Membrane Fusion | 1 | 2008 | 266 | 0.270 |
Why?
|
| Evolution, Molecular | 2 | 2017 | 1885 | 0.270 |
Why?
|
| Surface Properties | 1 | 2007 | 1161 | 0.240 |
Why?
|
| Chromosomes, Human | 3 | 2021 | 442 | 0.230 |
Why?
|
| Alleles | 1 | 2015 | 6898 | 0.230 |
Why?
|
| Algorithms | 1 | 2023 | 13981 | 0.200 |
Why?
|
| Cell Adhesion | 2 | 2008 | 3094 | 0.200 |
Why?
|
| Gene Targeting | 2 | 2016 | 839 | 0.200 |
Why?
|
| Chromosome Structures | 1 | 2021 | 11 | 0.200 |
Why?
|
| von Willebrand Factor | 3 | 2010 | 673 | 0.190 |
Why?
|
| Diploidy | 1 | 2021 | 132 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2018 | 3616 | 0.180 |
Why?
|
| Polymers | 1 | 2007 | 1621 | 0.180 |
Why?
|
| Mutation | 9 | 2020 | 29932 | 0.180 |
Why?
|
| Cytogenetic Analysis | 1 | 2021 | 271 | 0.180 |
Why?
|
| Chromosome Segregation | 2 | 2021 | 233 | 0.160 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2016 | 938 | 0.160 |
Why?
|
| Cell Membrane | 1 | 2008 | 3682 | 0.150 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2825 | 0.150 |
Why?
|
| Genomic Structural Variation | 1 | 2018 | 63 | 0.150 |
Why?
|
| Alu Elements | 1 | 2018 | 115 | 0.150 |
Why?
|
| Aneuploidy | 1 | 2021 | 551 | 0.150 |
Why?
|
| Self Tolerance | 1 | 2018 | 124 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2018 | 266 | 0.140 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2018 | 75 | 0.140 |
Why?
|
| RNA, Double-Stranded | 1 | 2018 | 295 | 0.130 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 244 | 0.130 |
Why?
|
| Genetic Linkage | 1 | 2021 | 2381 | 0.130 |
Why?
|
| Mitosis | 1 | 2020 | 1191 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2018 | 983 | 0.120 |
Why?
|
| Mechanical Phenomena | 2 | 2020 | 140 | 0.110 |
Why?
|
| S Phase | 1 | 2015 | 422 | 0.110 |
Why?
|
| DNA Mutational Analysis | 3 | 2017 | 4107 | 0.110 |
Why?
|
| Ploidies | 1 | 2013 | 275 | 0.110 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 724 | 0.110 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2015 | 330 | 0.100 |
Why?
|
| Calibration | 1 | 2015 | 816 | 0.100 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 294 | 0.100 |
Why?
|
| Gene Library | 1 | 2015 | 1060 | 0.100 |
Why?
|
| Cell Line | 3 | 2015 | 15620 | 0.100 |
Why?
|
| DNA, Neoplasm | 1 | 2017 | 1745 | 0.100 |
Why?
|
| Receptors, Androgen | 1 | 2018 | 1077 | 0.100 |
Why?
|
| Endonucleases | 1 | 2014 | 370 | 0.100 |
Why?
|
| Models, Biological | 1 | 2008 | 9467 | 0.100 |
Why?
|
| Multiple Myeloma | 2 | 2022 | 5130 | 0.100 |
Why?
|
| Dogs | 1 | 2015 | 3841 | 0.090 |
Why?
|
| Genotype | 2 | 2023 | 12960 | 0.090 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 4902 | 0.090 |
Why?
|
| Humans | 28 | 2023 | 760621 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2023 | 15789 | 0.080 |
Why?
|
| Biological Evolution | 1 | 2015 | 1074 | 0.080 |
Why?
|
| Arterioles | 1 | 2010 | 250 | 0.080 |
Why?
|
| Models, Chemical | 2 | 2010 | 614 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 935 | 0.080 |
Why?
|
| DNA Cleavage | 2 | 2021 | 57 | 0.080 |
Why?
|
| Adhesiveness | 1 | 2008 | 52 | 0.080 |
Why?
|
| Software | 3 | 2018 | 4419 | 0.080 |
Why?
|
| ADAM Proteins | 1 | 2009 | 240 | 0.070 |
Why?
|
| Blood Coagulation | 2 | 2010 | 1157 | 0.070 |
Why?
|
| Ligands | 3 | 2010 | 3276 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2013 | 1764 | 0.070 |
Why?
|
| Hemostasis | 1 | 2009 | 468 | 0.070 |
Why?
|
| Bone Marrow | 1 | 2016 | 2912 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2017 | 1628 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2008 | 638 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 6068 | 0.060 |
Why?
|
| Cell Survival | 1 | 2015 | 5797 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1741 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2717 | 0.060 |
Why?
|
| Computational Biology | 1 | 2016 | 3505 | 0.060 |
Why?
|
| Loss of Heterozygosity | 2 | 2016 | 659 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1846 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 3800 | 0.050 |
Why?
|
| Micronucleus, Germline | 1 | 2021 | 6 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2022 | 207 | 0.050 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 3826 | 0.050 |
Why?
|
| X Chromosome Inactivation | 1 | 2022 | 226 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3758 | 0.040 |
Why?
|
| Actomyosin | 1 | 2020 | 109 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2010 | 2520 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3707 | 0.040 |
Why?
|
| X Chromosome | 1 | 2022 | 815 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2014 | 3484 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2021 | 653 | 0.040 |
Why?
|
| Exodeoxyribonucleases | 1 | 2020 | 195 | 0.040 |
Why?
|
| Muramidase | 1 | 2018 | 169 | 0.040 |
Why?
|
| Gene Duplication | 1 | 2018 | 313 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 1131 | 0.040 |
Why?
|
| Genes, myc | 1 | 2018 | 395 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2021 | 716 | 0.030 |
Why?
|
| Ring Chromosomes | 1 | 2015 | 21 | 0.030 |
Why?
|
| Virus Integration | 1 | 2018 | 302 | 0.030 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2015 | 39 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1674 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3562 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2022 | 2648 | 0.030 |
Why?
|
| Protein Folding | 2 | 2009 | 867 | 0.030 |
Why?
|
| Anilides | 1 | 2018 | 409 | 0.030 |
Why?
|
| Models, Molecular | 3 | 2010 | 5434 | 0.030 |
Why?
|
| Animals | 5 | 2022 | 167963 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11345 | 0.030 |
Why?
|
| Genes, Essential | 1 | 2016 | 184 | 0.030 |
Why?
|
| Telomere-Binding Proteins | 1 | 2015 | 119 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2018 | 656 | 0.030 |
Why?
|
| Nuclear Envelope | 1 | 2015 | 163 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2008 | 6218 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2009 | 1982 | 0.030 |
Why?
|
| F-Box Proteins | 1 | 2015 | 202 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 1493 | 0.030 |
Why?
|
| Cell Division | 1 | 2021 | 4463 | 0.030 |
Why?
|
| Plasma Cells | 1 | 2016 | 591 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 7593 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2014 | 305 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 1056 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 1115 | 0.030 |
Why?
|
| Kinetics | 2 | 2010 | 6377 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 17790 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16939 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 1356 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2015 | 2176 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2020 | 2440 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1738 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2016 | 1895 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1792 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2919 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2016 | 944 | 0.020 |
Why?
|
| Hemorheology | 1 | 2010 | 144 | 0.020 |
Why?
|
| Binding Sites | 2 | 2009 | 6048 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2010 | 144 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2010 | 330 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 17624 | 0.020 |
Why?
|
| Pliability | 1 | 2008 | 58 | 0.020 |
Why?
|
| Optical Tweezers | 1 | 2009 | 84 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2618 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2005 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 2529 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 2008 | 421 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2009 | 599 | 0.020 |
Why?
|
| von Willebrand Diseases | 1 | 2009 | 132 | 0.020 |
Why?
|
| Protein Binding | 2 | 2010 | 9335 | 0.020 |
Why?
|
| Pyridines | 1 | 2018 | 2879 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1889 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5201 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2009 | 805 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 1229 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2008 | 2558 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 2907 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2018 | 5125 | 0.020 |
Why?
|
| Metals | 1 | 2008 | 736 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2009 | 1666 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 3446 | 0.010 |
Why?
|
| Base Sequence | 1 | 2014 | 12446 | 0.010 |
Why?
|
| Gene Expression | 1 | 2016 | 7588 | 0.010 |
Why?
|
| Male | 5 | 2022 | 359744 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4742 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5643 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2009 | 3969 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9411 | 0.010 |
Why?
|
| Phenotype | 1 | 2018 | 16546 | 0.010 |
Why?
|
| Mice | 2 | 2021 | 81208 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 22053 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10756 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10181 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13451 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5206 | 0.010 |
Why?
|
| Female | 3 | 2022 | 391270 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18137 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29658 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12103 | 0.010 |
Why?
|
| Middle Aged | 2 | 2018 | 220352 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 54303 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 21025 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 169152 | 0.000 |
Why?
|
| Adult | 1 | 2017 | 219994 | 0.000 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(61)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_